Abstract:Pharmaceutical evaluations of nanomedicines are of great significance for their further launch into industry and clinic. Near-infrared (NIR) fluorescence imaging plays essential roles in preclinical drug development by providing important insights into the biodistributions of drugs in vivo with deep tissue penetration and high spatiotemporal resolution. However, NIR-II fluorescence imaging has rarely been exploited for in vivo real-time pharmaceutical evaluations of nanomedicine. Herein, we developed a highly emissive NIR-II luminophore to establish a versatile nanoplatform to noninvasively monitor the in vivo metabolism of nanomedicines bound various polyethylene glycol (PEG) ligands in a real-time manner. An alternative D–A–D conjugated oligomer (DTTB) was synthesized to achieve NIR-II emission peaked at ∼1050 nm with high fluorescence QYs of 13.4% and a large absorption coefficient. By anchoring with the DTTB molecule, intrinsically fluorescent micelles were fabricated and bound with PEG ligands at various chain lengths. In vivo NIR-II fluorescence and photoacoustic imaging results revealed that an appropriate PEG chain length could effectively contribute to the longer blood circulation and better tumor targeting. In vivo therapeutic experiments also confirmed the optimized nanomedicines have efficient photothermal elimination of tumors and good biosafety. This work offered an alternative highly fluorescent NIR-II material and demonstrated a promising approach for real-time pharmaceutical evaluation of nanomedicine in vivo.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsnano.0c05885?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsnano.0c05885</a>.Additional experimental methods, the synthetic route to DTTB, NMR spectra of DTTB, HRMS spectra of DTTB, UV–vis–NIR spectra and emission spectra of DTTB, TEM image of and NMs, PA imaging stability test of ICG and solution, ex vivo NIR-II fluorescence imaging of major organs, photothermal properties tests of , photothermal ablation efficiency assessment of in vitro, and hemolysis analysis of (<a class="ext-link" href="/doi/suppl/10.1021/acsnano.0c05885/suppl_file/nn0c05885_si_001.pdf">PDF</a>)Real-time whole-body NIR-II fluorescence imaging video of the mice within 60 s after the intravenous injection of NMs (<a class="ext-link" href="/doi/suppl/10.1021/acsnano.0c05885/suppl_file/nn0c05885_si_002.avi">AVI</a>)Real-time whole-body NIR-II fluorescence imaging video of the mice within 60 s after the intravenous injection of NMs (<a class="ext-link" href="/doi/suppl/10.1021/acsnano.0c05885/suppl_file/nn0c05885_si_003.avi">AVI</a>)Real-time whole-body NIR-II fluorescence imaging video of the mice within 60 s after the intravenous injection of NMs (<a class="ext-link" href="/doi/suppl/10.1021/acsnano.0c05885/suppl_file/nn0c05885_si_004.avi">AVI</a>)This article has not yet been cited by other publications.

Effect of Ligand Nature on the Kinetics and the Bio-Distribution of Quantum Dots in Mice

Biocompatible organic dots with aggregation-induced emission for in vitro and in vivo fluorescence imaging

Quantum dot bioconjugates for imaging, labelling and sensing

Positive Sorption Behaviors in the Ligand Exchanges for Water-Soluble Quantum Dots and a Strategy for Specific Targeting

Application of quantum dots in biological imaging

Bioconjugated Quantum Dots for in Vivo Molecular and Cellular Imaging☆

(Invited) Designing Quantum Dots for Multiplexed Deep-Tissue Imaging in the NIR-II

Efficient Endocytosis of Inorganic Nanoparticles with Zwitterionic Surface Functionalization

A Systematic Examination of Surface Coatings on the Optical and Chemical Properties of Semiconductor Quantum Dots

'Green'-Synthesized Near-Infrared PbS Quantum Dots with Silica-Peg Dual-Layer Coating: Ultrastable and Biocompatible Optical Probes for in Vivo Animal Imaging.

Carbon Quantum Dots: in Vitro and in Vivo Studies on Biocompatibility and Biointeractions for Optical Imaging

Quantum dot-based nanoprobes for in vivo targeted imaging.

Pharmacokinetic Issues of Imaging with Nanoparticles: Focusing on Carbon Nanotubes and Quantum Dots

In Vivo Tumor-Targeted Fluorescence Imaging Using Near-Infrared Non-Cadmium Quantum Dots.

Cellular uptake, intracellular behavior, and acute/sub-acute cytotoxicity of a PEG-modified quantum dot with promising in-vivo biomedical applications

In Vivo Real-Time Pharmaceutical Evaluations of Near-Infrared II Fluorescent Nanomedicine Bound Polyethylene Glycol Ligands for Tumor Photothermal Ablation

Competitive Performance of Carbon “Quantum” Dots in Optical Bioimaging

Aqueous Synthesis of PEGylated Ag2S Quantum Dots and Their in Vivo Tumor Targeting Behavior.

Non-Cd Based Quantum Dots for Molecular Imaging

In a "nutshell": Intrinsically Radio-Labeled Quantum Dots.

Encapsulation and Solubilization of Ultrastable Quantum Dots with Multidentate Bilayer Ligands and Rheological Behaviour.